The Food and Drug Administration is approving cancer treatments at a faster rate than other new drugs.
Tufts University found FDA takes 10 months less to approve oncology drugs than others. Researchers said a smoother regulatory process has cut six months out of the process for drug makers compared with a decade ago. But they found that for non-cancer drugs the FDA takes longer than its European counterparts. The EU approves those drugs in about two-thirds of the time than it takes the FDA.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.